Stoke Therapeutics, Inc. (STOK)

CIK 1623526 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Stoke Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 202640001780088-26-000021
Aug 18, 202640001966716-26-000012
Aug 18, 202640001780088-26-000019
Aug 18, 202640001522780-26-000007
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003525
Aug 12, 2026SCHEDULE 13G/A0000947263-26-000071
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002141
Aug 5, 202640001780088-26-000017
Aug 3, 20261440001950047-26-007565
Aug 3, 2026424B50001193125-26-330792
Aug 3, 202610-Q0001193125-26-330557
Aug 3, 20268-K0001193125-26-330804
Aug 3, 2026S-80001193125-26-330706
Aug 3, 20268-K0001193125-26-330537
Jul 17, 202640001404955-26-000006
Jul 17, 202640001858760-26-000008
Jul 17, 202630001858760-26-000007
Jul 6, 202640001780088-26-000015
Jul 1, 20261440001950047-26-006742
Jun 30, 20268-K0001193125-26-289409
Jun 18, 202640001966716-26-000010
Jun 16, 20261440001950047-26-006194
Jun 5, 202640001181556-26-000007
Jun 5, 202640001522780-26-000004
Jun 5, 202640001640069-26-000002